Main > > >ARTHRITIS. *

Rheuma.>Psoriatic Arthritis. TREAT.: Apremilast Tablets.
Oral PDE-4 Inhibitor.
CA Approval Date : 2020. 02.12.
EU Approval Date : 2015. 01.15.
JP Approval Date : 2016. 12.20.
USA Approval Date: 2014. 03.21.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.11.




Rheuma.>Psoriatic Arthritis. TREAT.: InflixiMAb axxq BioSimilar.
USA Approval Date: 2019. 12.06.
(*) Company; TradeMark & Web-Site Avai-
lable on Request.
UpDate: 2020. 04.11.




Rheuma.>Rheumatoid Arthritis. TREAT.:
InflixiMAb axxq BioSimilar.
USA Approval Date: 2019. 12.06.
(*) Company; TradeMark & Web-Site Avai-
lable on Request.
UpDate: 2020. 04.11.




TREAT.: AdalimuMAb. BioSimilar.
Enthesis-Related Arthritis.
Polyarticular Juvenile Idiopathic Arth.
Psoriatic Arthritis
Rheumatoid Arthritis.
EU Launch Date: 2018. 10.15.
(*) Company : Amgen
TradeMark: Amgevita
UpDate: 2018. 10.30.




TREAT.: AdalimuMAb. BioSimilar.
Enthesis-Related Arthritis.
Polyarticular Juvenile Idiopathic Arth.
Psoriatic Arthritis
Rheumatoid Arthritis.
EU Approval Date: 2018. 09.20.
EU Launch Date : 2018. 10.19.
(*) Company: Mylan
UpDate: 2018. 10.30.




TREAT.: AdalimuMAb. BioSimilar.
Enthesis-Related Arthritis.
Polyarticular Juvenile Idiopathic Arth.
Psoriatic Arthritis
Rheumatoid Arthritis.
EU Launch Date: 2018. 10.17.
(*) Company: Samsung Bioepis
UpDate: 2018. 10.17.


>ARTHRITIS. *'s products
This section has no products